CD19 and neoplasm: Compared with CD19R+ T cells, CD19RCD28+ T cells exhibited superior proliferation without exogenous IL-2, produced IL-2, propagated efficiently, and upregulated the anti-apoptotic protein Bcl-XL after CD19+ tumor cell stimulation.